NEOGENOMICS EUROPE
LIVE

Serial Number

87580599

Owner

NEOGENOMICS LABORATORIES, INC.

Attorney

Anessa O. Kramer

Filing Date

Aug 23, 2017

Add to watchlist:

No watchlists yet
View on USPTO

NEOGENOMICS EUROPE Trademark

Serial Number: 87580599 • Registration: 6471194

NEOGENOMICS EUROPE is a trademark filed by NEOGENOMICS LABORATORIES, INC. on August 23, 2017. The trademark is classified under Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

NEOGENOMICS LABORATORIES, INC. (85 trademarks)

12701 COMMONWEALTH DRIVE, SUITE 9
FORT MYERS, FL 33913

Entity Type: 03

Trademark Details

Filing Date

August 23, 2017

Registration Date

August 31, 2021

Published for Opposition

May 8, 2018

Goods & Services

Medical diagnostic testing services in the field of human disease and human medical conditions; medical testing for diagnostic or treatment purposes; providing medical information to others in the field of human disease, human medical conditions, medical diagnostic testing services and medical testing for diagnostic or treatment purposes; providing an Internet website portal featuring medical information in the field of human disease, and human medical conditions, medical diagnostic testing services, medical testing for diagnostic or treatment purposes; providing cloud-based medical information to others in the field of human disease, human medical conditions, medical diagnostic testing services, and medical testing for diagnostic or treatment purposes; medical testing for the detection of cancer; medical testing for the detection of genetic information pertaining to human disease; Medical diagnostic testing to aid in diagnosis, prognosis and therapy selection; oncology reference laboratory services

Genetic mapping for scientific purposes; gene sequencing; molecular sequencing; cancer study and analysis; clinical study and testing of cells; medical and scientific research information in the field of gene sequencing, molecular sequencing, cancer study and analysis, clinical study and testing of cells; scientific research in the field of gene sequencing, molecular sequencing, cancer study and analysis, clinical study and testing of cells, and cancer; providing information to others in the fields of oncology, pathology and gene sequencing, molecular sequencing, cancer study and analysis, clinical study and testing of cells scientific testing and research services and clinical scientific testing; providing an internet website portal featuring gene sequencing, molecular sequencing, cancer study and analysis, clinical study and testing of cells; scientific and medical research information in the fields of scientific testing and research services, medical research services, and clinical scientific testing; providing cloud-based scientific and medical research information to others in the field of scientific testing and research services, medical research services, and clinical scientific testing; providing temporary use of online non-downloadable software for analysis of medical test results; temporary use of online non-downloadable software for enhancement of analysis, research, and review of information pertaining to medical, scientific, genetic, testing and analysis, and information and pertaining to such testing and analysis; software as a service (SAAS) services featuring software for analysis of medical test results; non-downloadable computer software for enhancement of analysis, research, and review of information pertaining to medical, scientific, genetic, testing and analysis, and information pertaining to testing and analysis; providing medical research and scientific research information in the field of oncology ; genetic testing, rna testing and sequencing; scientific testing and research services in the field of human disease and human medical conditions; providing medical research services in the field of human disease and human medical conditions; providing clinical scientific testing services and medical research and testing in the field of human disease and human medical conditions; clinical laboratory services, oncology reference laboratory services, providing information, interactive information, and reports, to others in the field of pathology, diagnostic testing, oncology testing; consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; medical and scientific research, namely, conducting clinical trials for others; conducting research and clinical trials for others relating to medical devices and pharmaceuticals

Filing History

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Feb 1, 2023 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 1, 2023 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Feb 1, 2023 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Feb 1, 2023 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Feb 1, 2023 COAR
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Nov 10, 2022 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Nov 10, 2022 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Nov 10, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Nov 10, 2022 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Nov 10, 2022 COAR
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jun 13, 2022 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jun 13, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jun 13, 2022 REAP
REGISTERED-PRINCIPAL REGISTER
Aug 31, 2021 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Jul 29, 2021 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Jul 28, 2021 CNPR
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 20, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 19, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 19, 2021 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jul 19, 2021 GNRN
NON-FINAL ACTION E-MAILED
Jul 19, 2021 GNRT
SU - NON-FINAL ACTION - WRITTEN
Jul 19, 2021 CNRT
STATEMENT OF USE PROCESSING COMPLETE
Jul 8, 2021 SUPC
USE AMENDMENT FILED
Jul 1, 2021 IUAF
TEAS STATEMENT OF USE RECEIVED
Jul 1, 2021 EISU
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jul 1, 2021 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jul 1, 2021 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jul 1, 2021 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jul 1, 2021 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jul 1, 2021 COAR
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 18, 2020 EXRA
SOU EXTENSION 5 GRANTED
Dec 17, 2020 EX5G
SOU EXTENSION 5 FILED
Dec 14, 2020 EXT5
SOU TEAS EXTENSION RECEIVED
Dec 14, 2020 EEXT
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Dec 14, 2020 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Dec 14, 2020 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Dec 14, 2020 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Dec 14, 2020 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Dec 14, 2020 COAR
ASSIGNED TO EXAMINER
Jul 23, 2020 DOCK
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 7, 2020 EXRA
SOU EXTENSION 4 GRANTED
Jul 6, 2020 EX4G
SOU EXTENSION 4 FILED
Jul 1, 2020 EXT4
SOU TEAS EXTENSION RECEIVED
Jul 1, 2020 EEXT
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jul 1, 2020 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jul 1, 2020 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jul 1, 2020 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jul 1, 2020 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jul 1, 2020 COAR
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 21, 2019 EXRA
SOU EXTENSION 3 GRANTED
Dec 20, 2019 EX3G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Dec 20, 2019 AITU
SOU EXTENSION 3 FILED
Dec 16, 2019 EXT3
SOU TEAS EXTENSION RECEIVED
Dec 16, 2019 EEXT
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Jul 3, 2019 ASCK
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 27, 2019 EXRA
SOU EXTENSION 2 GRANTED
Jun 25, 2019 EX2G
SOU EXTENSION 2 FILED
Jun 25, 2019 EXT2
SOU TEAS EXTENSION RECEIVED
Jun 25, 2019 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 25, 2018 EXRA
SOU EXTENSION 1 GRANTED
Dec 21, 2018 EX1G
SOU EXTENSION 1 FILED
Dec 21, 2018 EXT1
SOU TEAS EXTENSION RECEIVED
Dec 21, 2018 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jul 3, 2018 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 8, 2018 NPUB
PUBLISHED FOR OPPOSITION
May 8, 2018 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 18, 2018 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 29, 2018 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 7, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 7, 2018 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 5, 2018 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 1, 2017 GNRN
NON-FINAL ACTION E-MAILED
Dec 1, 2017 GNRT
NON-FINAL ACTION WRITTEN
Dec 1, 2017 CNRT
ASSIGNED TO EXAMINER
Nov 29, 2017 DOCK
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Sep 11, 2017 AMPX
ASSIGNED TO LIE
Sep 10, 2017 ALIE
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 29, 2017 NWOS
TEAS VOLUNTARY AMENDMENT RECEIVED
Aug 28, 2017 PARI
NEW APPLICATION ENTERED
Aug 26, 2017 NWAP